Evidence map›Paper›PMID 23754445›Full record

ArticleProtein science : a publication of the Protein Society2013

Controlling the diameter, monodispersity, and solubility of ApoA1 nanolipoprotein particles using telodendrimer chemistry.

Wei He, Juntao Luo, Feliza Bourguet, Li Xing, Sun K Yi, Tingjuan Gao, Craig Blanchette, Paul T Henderson, Edward Kuhn, Mike Malfatti and 4 more

Open access · greenAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Cationic HDL mimetics enhance in vivo delivery of self-replicating mRNA.Nanomedicine : nanotechnology, biology, and medicine · 2020
    Article
  8. Article
  9. Review
  10. Article
  11. Cell-free production of a functional oligomeric form of aThe Journal of biological chemistry · 2017
    Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Wei HeNSF Center for Biophotonics Science and Technology, Sacramento, California, 95817, USA.
Juntao Luo
Feliza Bourguet
Li Xing
Sun K Yi
Tingjuan Gao
Craig Blanchette
Paul T Henderson
Edward Kuhn
Mike Malfatti
William J Murphy
R Holland Cheng
Kit S Lam
Matthew A Coleman
University of California Davis Medical Center · USLawrence Livermore National Laboratory · USUniversity of California, Davis · USSUNY Upstate Medical University · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
Therapeutic Targeting Agents for Ovarian CancerR01CA115483 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI LAM, KIT S · 2005 to 2019
$5.5M
Characterization of Erbb Receptors in NanoparticlesR01CA155642 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI COLEMAN, MATTHEW ADRIAN, HENDERSON, PAUL THOMAS · 2011 to 2015
$1.6M
Size-tunable cancer nanotherapeuticsR01CA140449 · NCI · UPSTATE MEDICAL UNIVERSITY · PI LUO, JUNTAO · 2010 to 2014
$1.6M
NCI NIH HHS P30 CA093373NCI NIH HHS R01CA115483NCI NIH HHS R01CA140449NCI NIH HHS R01 CA155642NCI NIH HHS R01-CA155642-01A
6 · The paper itself

Abstract

Nanolipoprotein particles (NLPs) are nanometer-scale discoidal particles that feature a phospholipid bilayer confined within an apolipoprotein "scaffold," which are useful for solubilizing hydrophobic molecules such as drugs and membrane proteins. NLPs are synthesized either by mixing the purified apolipoprotein with phospholipids and other cofactors or by cell-free protein synthesis followed by self-assembly of the nanoparticles in the reaction mixture. Either method can be problematic regarding the production of homogeneous and monodispersed populations of NLPs, which also currently requires multiple synthesis and purification steps. Telodendrimers (TD) are branched polymers made up of a dendritic oligo-lysine core that is conjugated to linear polyethylene glycol (PEG) on one end, and the lysine "branches" are terminated with cholic acid moieties that enable the formation of nanomicelles in aqueous solution. We report herein that the addition of TD during cell-free synthesis of NLPs produces unique hybrid nanoparticles that have drastically reduced polydispersity as compared to NLPs made in the absence of TD. This finding was supported by dynamic light scattering, fluorescence correlation spectroscopy, and cryo transmission electron microscopy (Cryo-EM). These techniques demonstrate the ability of TDs to modulate both the NLP size (6-30 nm) and polydispersity. The telodendrimer NLPs (TD-NLPs) also showed 80% less aggregation as compared to NLPs alone. Furthermore, the versatility of these novel nanoparticles was shown through direct conjugation of small molecules such as fluorescent dyes directly to the TD as well as the insertion of a functional membrane protein.

Indexed as

Apolipoprotein A-ICell-Free SystemCryoelectron MicroscopyDendrimersMembrane ProteinsNanoparticlesProtein EngineeringSpectrometry, FluorescenceApolipoprotein A-IDendrimersMembrane Proteinsapolipoproteincell-free expressionmembrane proteinmono-dispersitynanolipoproteinsnanotechnologytelodendrimer

Identifiers

PMID23754445
PMCPMC3832044
OpenAlexW2098150724

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.